Comorbidities increase cardiovascular disease risk and underscore the need for advanced blood pressure control.
Understanding why patients fail to achieve blood pressure goals is a first step towards improved management of hypertension.
α1-blockade causes vasodilation, which can lower peripheral resistance and improve peripheral blood flow.
Vasodilating β-blockers have a low incidence of common side effects that most concern physicians.